UCHL1 and Alzheimer disease: Firstly, increased levels of oxidized and carbonyl-modified UCH-L1 were found in brains of AD and PD patients compared to control subjects [120], where reactive metabolites such as endogenous and oxidized dopamine can induce unfolding and aggregation of UCH-L1 and result in decreased cell viability [76,150].